NAFTA Revision, H.R. 1865, and Biologics (Pharma) Switcheroo
Sigh . . . If the general public has not caught it, there are some of us who watch the political mechanizations by commercial healthcare to improve their lot in Congress. I know the public has not caught this switcheroo in Congress causing them to look good (and boast of it) in removing new drug […]
